Turning Back the Sickle Cell Disease: A New Drug into Play
Keyword(s):
Researchers at the Fulcrum Therapeutics developed a bioavailable drug candidate called FTX 6058 – (a novel small molecular fetal haemoglobin inducer for sickle cell disease) that can restore the body’s ability to produce fetal haemoglobin
2012 ◽
Vol 2
(2)
◽
pp. 57-60
Keyword(s):
1982 ◽
Vol 52
(3)
◽
pp. 455-463
◽
Keyword(s):
1989 ◽
Vol 72
(3)
◽
pp. 434-438
◽
Keyword(s):
1992 ◽
Vol 67
(4)
◽
pp. 517-520
◽
Keyword(s):
Keyword(s):
2018 ◽
Vol 183
(5)
◽
pp. 807-811
◽
Keyword(s):
2018 ◽
Vol 23
(2)
◽
pp. 235-244
◽
Keyword(s):
2017 ◽
Vol 117
(11)
◽
pp. 20-21
2018 ◽
Vol 6
(5)
◽
pp. 329-343
◽